DOI: 10.12890/2020_002003

Portal Vein Thrombosis Secondary to Occult Polycythemia Vera

Authors

  • Antón FR Gameiro Hospital do SAMS, Lisbon, Portugal
  • António Robalo Nunes Hospital do SAMS, Lisbon, Portugal
  • Paula Guerra Hospital do SAMS, Lisbon, Portugal
  • Estela Mateus Hospital do SAMS, Lisbon, Portugal
  • Fátima Fernandes Hospital do SAMS, Lisbon, Portugal

antonfrg@gmail.com

Keywords

Ascites, portal vein thrombosis, polycythemia vera, anaemia, iron deficiency

Abstract

Portal vein thrombosis (PVT) is an uncommon finding in patients without cirrhosis. The underlying aetiology is challenging and the condition has a wide differential diagnosis. We present a case of PVT in an anaemic patient with chronic iron and folic acid deficiency masking underlying polycythemia vera (PV). Only a careful review of the patient’s clinical history allowed the identification of a short period of laboratory erythrocytosis, 6 months before the clinical onset of PVT, while the patient was on iron and folic acid supplementation. The finding raised clinical suspicion of PV previously masked by iron deficiency anaemia. Subsequent investigation confirmed the presence of the JAK2 V617F mutation and, ultimately, showed that the patient met all diagnostic criteria for PV. Myeloproliferative disorders (MPD) are associated with systemic prothrombotic states. PV is distinguished clinically from other MPD by the presence of increased red blood cell mass. Moreover, patients with abnormal haematocrit values in the pre-JAK2 V617F era may have had occult or latent PV. Diagnosis confirmation requires a combination of major and minor criteria to capture occasional cases of occult PV. This case emphasizes the importance of always considering MPD in the aetiological investigation of PVT, even in patients who apparently do not fulfil the diagnostic criteria.

View the entire article

Downloads

References

  1. Michiels JJ. Erythromelalgia and vascular complications in polycythemia vera. Semin Thromb Hemost 1997;23:441–454.
  2. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 2019;94(1):133–143.
  3. Trebicka J, Strassburg CP. Etiology and complications of portal vein thrombosis. Viszeralmedizin 2014;30:375–380.
  4. Ginzburg YZ, Feola M, Zimran E, Varkonyi J, Ganz T, Hoffman R. Dysregulated iron metabolism in polycythemia vera: etiology and consequences. Leukemia 2018;32:2105–2116.
  5. Kambali S, Taj A. Polycythemia vera masked due to severe iron deficiency anemia. Hematol Oncol Stem Cell Ther 2018;11(1):38–40.
  6. Dentali F, Squizzato A, Brivio L, Appio L, Campiotti L, Crowther M, et al. JAK2V617F mutation for the early diagnosis of Ph– myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood 2009;113:5617–5623.

Published

2020-11-02

How to Cite

1.
Gameiro AF, Robalo Nunes A, Guerra P, Mateus E, Fernandes F. Portal Vein Thrombosis Secondary to Occult Polycythemia Vera . EJCRIM [Internet]. 2020 Nov. 2 [cited 2026 Nov. 3];7(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2003